NCT01845532View on ClinicalTrials.gov

Analgesic Effect of Trigger Point Injection and EMLA for Shoulder Pain in Laparoscopic Hysterectomy

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2014

Conditions
Myoma of Uterus
Interventions
DRUG

TPI

Trigger point injection with 25G needle on the shoulder before surgery(0.5% procaine, 0.25\~0.5% lidocaine, 0.125% bupivacaine)

DRUG

EMLA cream

EMLA cream with occluding dressing on the shoulder before surgery(5% of eutectic mixture with 2.5% lidocaine and 2.5% prilocaine)

Trial Locations (1)

120-752

Severance hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01845532 - Analgesic Effect of Trigger Point Injection and EMLA for Shoulder Pain in Laparoscopic Hysterectomy | Biotech Hunter | Biotech Hunter